BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 19298339)

  • 1. Meta-analysis: the effect of supplementation with lactoferrin on eradication rates and adverse events during Helicobacter pylori eradication therapy.
    Zou J; Dong J; Yu XF
    Helicobacter; 2009 Apr; 14(2):119-27. PubMed ID: 19298339
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Meta-analysis: the effect of supplementation with probiotics on eradication rates and adverse events during Helicobacter pylori eradication therapy.
    Tong JL; Ran ZH; Shen J; Zhang CX; Xiao SD
    Aliment Pharmacol Ther; 2007 Jan; 25(2):155-68. PubMed ID: 17229240
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Meta-analysis: Lactobacillus containing quadruple therapy versus standard triple first-line therapy for Helicobacter pylori eradication.
    Zou J; Dong J; Yu X
    Helicobacter; 2009 Oct; 14(5):97-107. PubMed ID: 19751434
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Meta-analysis: efficacy of bovine lactoferrin in Helicobacter pylori eradication.
    Sachdeva A; Nagpal J
    Aliment Pharmacol Ther; 2009 Apr; 29(7):720-30. PubMed ID: 19183156
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Meta-analysis: Helicobacter pylori eradication therapy vs. antisecretory non-eradication therapy for the prevention of recurrent bleeding from peptic ulcer.
    Gisbert JP; Khorrami S; Carballo F; Calvet X; Gene E; Dominguez-Muñoz E
    Aliment Pharmacol Ther; 2004 Mar; 19(6):617-29. PubMed ID: 15023164
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Smoking increases the treatment failure for Helicobacter pylori eradication.
    Suzuki T; Matsuo K; Ito H; Sawaki A; Hirose K; Wakai K; Sato S; Nakamura T; Yamao K; Ueda R; Tajima K
    Am J Med; 2006 Mar; 119(3):217-24. PubMed ID: 16490464
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Meta-analysis of the efficacy and safety of Lactobacillus-containing and Bifidobacterium-containing probiotic compound preparation in Helicobacter pylori eradication therapy.
    Wang ZH; Gao QY; Fang JY
    J Clin Gastroenterol; 2013 Jan; 47(1):25-32. PubMed ID: 23090045
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative study of Helicobacter pylori eradication rates of twice-versus four-times-daily amoxicillin administered with proton pump inhibitor and clarithromycin: a randomized study.
    Kim SY; Lee SW; Jung SW; Koo JS; Yim HJ; Park JJ; Chun HJ; Lee HS; Choi JH; Kim CD; Ryu HS
    Helicobacter; 2008 Aug; 13(4):282-7. PubMed ID: 18665938
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Meta-analysis: the influence of pre-treatment with a proton pump inhibitor on Helicobacter pylori eradication.
    Janssen MJ; Laheij RJ; de Boer WA; Jansen JB
    Aliment Pharmacol Ther; 2005 Feb; 21(4):341-5. PubMed ID: 15709984
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of Probiotic Supplementation Therapy for Helicobacter pylori Eradication: A Meta-Analysis of Randomized Controlled Trials.
    Lü M; Yu S; Deng J; Yan Q; Yang C; Xia G; Zhou X
    PLoS One; 2016; 11(10):e0163743. PubMed ID: 27723762
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lafutidine versus lansoprazole in combination with clarithromycin and amoxicillin for one versus two weeks for Helicobacter pylori eradication in Korea.
    Kim N; Park SH; Seo GS; Lee SW; Kim JW; Lee KJ; Shin WC; Kim TN; Park MI; Park JJ; Hong SJ; Shim KN; Kim SW; Shin YW; Chang YW; Chun HJ; Lee OJ; Jeon WJ; Park CG; Cho CM; Park CH; Won SY; Lee GH; Park KS; Shin JE; Kim HU; Park JY; Chae HS; Song GA; Kim JG; Yoon BC; Seol S; Jung HC; Chung IS
    Helicobacter; 2008 Dec; 13(6):542-9. PubMed ID: 19166420
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Meta-analysis: sequential therapy for Helicobacter pylori eradication in children.
    Horvath A; Dziechciarz P; Szajewska H
    Aliment Pharmacol Ther; 2012 Sep; 36(6):534-41. PubMed ID: 22827718
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sequential therapy vs. standard triple therapies for Helicobacter pylori infection: a meta-analysis.
    Tong JL; Ran ZH; Shen J; Xiao SD
    J Clin Pharm Ther; 2009 Feb; 34(1):41-53. PubMed ID: 19125902
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Meta-analysis: the effects of Saccharomyces boulardii supplementation on Helicobacter pylori eradication rates and side effects during treatment.
    Szajewska H; Horvath A; Piwowarczyk A
    Aliment Pharmacol Ther; 2010 Nov; 32(9):1069-79. PubMed ID: 21039671
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pylera for the eradication of Helicobacter pylori infection.
    Saleem A; Qasim A; O'Connor HJ; O'Morain CA
    Expert Rev Anti Infect Ther; 2009 Sep; 7(7):793-9. PubMed ID: 19735221
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Helicobacter pylori eradication therapy success regarding different treatment period based on clarithromycin or metronidazole triple-therapy regimens.
    Filipec Kanizaj T; Katicic M; Skurla B; Ticak M; Plecko V; Kalenic S
    Helicobacter; 2009 Feb; 14(1):29-35. PubMed ID: 19191893
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Eradicating Helicobacter pylori in peptic ulcer disease reduces medical costs in the community.
    Sone Y; Kumada T; Toyoda H; Yokoyama M; Kato M; Asaka M
    Helicobacter; 2008 Oct; 13(5):346-51. PubMed ID: 19250509
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Azithromycin effect on helicobacter pylori eradication: double blind randomized clinical trial.
    Rogha M; Pourmoghaddas Z; Rezaee M; Shirneshan K; Shahi Z
    Hepatogastroenterology; 2009; 56(91-92):722-4. PubMed ID: 19621690
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of Helicobacter pylori eradication on incidence of gastric cancer in human and animal models: underlying biochemical and molecular events.
    Kabir S
    Helicobacter; 2009 Jun; 14(3):159-71. PubMed ID: 19702845
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cumulative H. pylori eradication rates in clinical practice by adopting first and second-line regimens proposed by the Maastricht III consensus and a third-line empirical regimen.
    Rokkas T; Sechopoulos P; Robotis I; Margantinis G; Pistiolas D
    Am J Gastroenterol; 2009 Jan; 104(1):21-5. PubMed ID: 19098844
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.